B2Gold stock rides gold’s record run — here’s what matters before Monday
24 January 2026
1 min read

B2Gold stock rides gold’s record run — here’s what matters before Monday

New York, Jan 24, 2026, 09:21 (EST) — Market closed

  • B2Gold shares climbed 1.6% on Friday, closing at $5.29 and pushing their two-day rally further.
  • The miner scheduled its fourth-quarter and full-year 2025 results, plus 2026 guidance, for Feb. 18.
  • Gold surged close to $5,000 an ounce, while silver climbed above $100 an ounce, boosting sentiment among gold-related stocks.

B2Gold Corp shares climbed on Friday, buoyed by a renewed rally in precious metals and a company filing confirming the upcoming earnings date. 1

With U.S. markets closed for the weekend, BTG’s short-term trajectory depends on two key factors: if gold stays close to record highs come Monday, and whether investors continue to focus on the company’s February results and outlook. 2

B2Gold finished at $5.29 on Jan. 23, edging up from $5.20 the previous day following a strong rally on Jan. 22. Trading volumes have remained elevated in recent sessions. 1

Late Thursday, the Vancouver-based miner announced it will release its fourth-quarter and full-year 2025 results after North American markets close on Feb. 18. The company plans to provide 2026 guidance — covering output, costs, and spending — during a conference call the following morning. 3

Timing is key as miners have been moving more like a macro play than just individual stocks. On Friday, gold surged to a record intraday peak of $4,988 an ounce, while silver jumped past $100 an ounce, drawing increased capital into the sector. 2

“Silver is caught up in a self-driven frenzy,” StoneX analyst Rhona O’Connell said, cautioning that the rapid gains leave scant room for any setbacks. 2

BofA strategist Michael Widmer pegged a “fundamentally justified” silver price near $60, while BNP Paribas’ David Wilson warned that profit-taking might come “sooner rather than later” following the late-2025 surge. Such cautionary comments can quickly weigh on the market if bullion starts to falter. 2

Country risk is also a factor. Mali’s president moved this week to tighten direct control over the mining sector, underscoring how quickly regulatory shifts can hit operators there — including B2Gold, which counts Mali among its operating regions. 4

Traders are set to focus on the Federal Reserve’s policy meeting scheduled for Jan. 27-28, along with the Jan. 28 press conference. Markets will be looking for clues that could move the dollar or influence rate expectations—two critical factors for gold prices. 5

BTG won’t face another major catalyst until mid-February, yet Monday’s open will reveal whether the recent gains stem from metal-driven momentum or from traders positioning ahead of B2Gold’s upcoming earnings and 2026 guidance. 3

Stock Market Today

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
Home Depot shares rose 0.7% to $385.15 Friday, trading between $379.10 and $386.37. Investors await a delayed U.S. jobs report Wednesday and CPI data Friday, both postponed by a brief government shutdown. Home Depot reports fourth-quarter earnings Feb. 24. The Dow closed above 50,000 for the first time.
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Redwire stock rallies again on Golden Dome talk — what RDW investors are watching next
Previous Story

Redwire stock rallies again on Golden Dome talk — what RDW investors are watching next

Microsoft stock jumps into earnings week as UBS trims target and outage lingers
Next Story

Microsoft stock jumps into earnings week as UBS trims target and outage lingers

Go toTop